-
APGN Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Apexigen (APGN)
Company Profile
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 9.37 mm | 9.37 mm | 9.37 mm | 9.37 mm | 9.37 mm | 9.37 mm |
Cash burn (monthly) | 1.12 mm | 189.58 k | 2.05 mm | 2.32 mm | 1.00 mm | 2.19 mm |
Cash used (since last report) | 21.59 mm | 3.65 mm | 39.56 mm | 44.68 mm | 19.28 mm | 42.26 mm |
Cash remaining | -12.22 mm | 5.72 mm | -30.19 mm | -35.31 mm | -9.91 mm | -32.89 mm |
Runway (months of cash) | -10.9 | 30.1 | -14.7 | -15.2 | -9.9 | -15.0 |
13F holders | Current |
---|---|
Total holders | 36 |
Opened positions | 17 |
Closed positions | 2 |
Increased positions | 4 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 1.35 bn |
Total shares | 7.00 mm |
Total puts | 0.00 |
Total calls | 16.45 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Decheng Capital China Life Sciences USD Fund II | 1.89 mm | $0.00 |
Decheng Capital Management III | 1.89 mm | $814.28 mm |
3E Bioventures Capital | 1.14 mm | $0.00 |
Fan Yu | 401.76 k | $172.68 mm |
Vanguard | 256.94 k | $110.43 mm |
BLK BlackRock | 213.83 k | $91.91 mm |
Geode Capital Management | 178.76 k | $76.83 mm |
Kepos Capital | 150.00 k | $5.00 k |
Walleye Capital | 106.21 k | $3.61 mm |
Yakira Capital Management | 85.00 k | $2.89 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Aug 23 | Hsu Frank J. | Common Stock | Sale back to company | Dispose D | No | No | 0 | 16,354 | 0.00 | 0 |
23 Aug 23 | Hsu Frank J. | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.46 | 27,000 | 66.42 k | 0 |
23 Aug 23 | Hsu Frank J. | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.79 | 224,872 | 1.08 mm | 0 |
23 Aug 23 | Francis Willard Sarena | Common Stock | Sale back to company | Dispose D | No | No | 0 | 124,296 | 0.00 | 0 |
23 Aug 23 | Francis Willard Sarena | Common Stock | Payment of exercise | Dispose F | No | No | 0.3851 | 31,123 | 11.99 k | 124,296 |
23 Aug 23 | Francis Willard Sarena | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.79 | 269,847 | 1.29 mm | 0 |
23 Aug 23 | Herb Cross | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.65 | 100,000 | 265.00 k | 0 |
23 Aug 23 | Herb Cross | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.94 | 34,084 | 236.54 k | 0 |
23 Aug 23 | Dupont Jakob | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.65 | 100,000 | 265.00 k | 0 |
23 Aug 23 | Dupont Jakob | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.59 | 20,489 | 94.04 k | 0 |